Perrigo (PRGO +0.2%) announces that it nabbed final FDA approval for Desloratadine. The product...

|About: Perrigo Company (PRGO)|By:, SA News Editor

Perrigo (PRGO +0.2%) announces that it nabbed final FDA approval for Desloratadine. The product - set for commercial launch in July 2012 - is a generic version of Schering-Plough's Clarinex allergy relief treatment.